Pelage Pharmaceuticals, Inc. — Form D
Pelage Pharmaceuticals, Inc. of LOS ANGELES, CA, a company, filed a Form D exempt-offering notice with the SEC on 2023-06-28. The offering totals $16.7M, of which $16.7M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2023-06-28
- Form: D
- Accession: 0001982875-23-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $16.7M
- Amount sold: $16.7M
- Investors: 6
- Date of first sale: 2023-06-20
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-485380
Issuer
- Name: Pelage Pharmaceuticals, Inc.
- CIK: 0001982875
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 907 WESTWOOD BLVD #384, LOS ANGELES, CA, 90024
- Phone: 949-244-9904
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Cathy Edward Friedman | Director | Los Angeles, CA |
| Nathan Edward Wheeler | Executive Officer | Los Angeles, CA |
| William Edward Lowry | Director | Los Angeles, CA |
| William Edward Lowry | Executive Officer | Los Angeles, CA |
| Christina Edward Weng | Executive Officer | Los Angeles, CA |
| Daniel Gil | Director | Los Angeles, CA |
| Daniel Gil | Executive Officer | Los Angeles, CA |
| Richard Edward Heyman | Director | Los Angeles, CA |
| Heather Edward Christofk | Executive Officer | Los Angeles, CA |
Other filings by this issuer (2)
More